Skip to main content

Natera, Inc.

NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001604821

In the last 90 days, Natera, Inc. insiders filed 0 open-market purchases and 30 sales; 850 institutions reported holding it in 13F filings for Q2 2026, worth $37.2B in total; 5 superinvestors hold it, including Duquesne Family Office and Coatue Management.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Natera, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
30 filings
8 insiders, $89.6M in total
Insiders trading
8
Net value
−$89.6M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Natera, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Natera, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Sheena JonathanDirector, Other: CO-FOUNDER9,000IndirectSep 25, 202632
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS109,914Sep 18, 202622
Rabinowitz MatthewEXECUTIVE CHAIRMAN0IndirectSep 16, 202615
Chapman Steven LeonardCEO AND PRESIDENT98,199Sep 3, 202617
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER197,257Aug 28, 202615
Brophy Michael BurkesCHIEF FINANCIAL OFFICER51,637Aug 5, 202613
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER170,073Aug 5, 202617
Chapman Rowan EDirector4,663Jul 17, 20268
Botha RoelofDirector4,585Jun 30, 20266
Rosenman HermDirector5,927Jun 30, 20265
Lynch Thomas J. Jr.Director1,905Jun 30, 20261
Baynes Roy D.Director20,158Jun 30, 20265
Marcus Gail BoxerDirector7,852Jun 30, 20265
Bertagnolli MonicaDirector7,020Jun 30, 20264
Rubin EricDirector2,204Jun 30, 20263
Brinkley Ruth WilliamsDirector5,475Apr 28, 20263
Healy JamesDirector46,260Apr 29, 20250
Schueren Robert AlanCHIEF OPERATING OFFICER24,091Jan 31, 20230
Cozzens Todd CDirector15,813May 27, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 30, 2024 (view filing)May 282 daysFesko JohnPRESIDENT, CHIEF BUS. OFFICERSSale−1.44K$109.96−$158.1K−1.3%109.9K after10b5-1
May 30, 2024 (view filing)May 282 daysChapman Rowan EDirectorSSale−4.86K$109.09−$529.7K−49.2%5.00K after
May 24, 2024 (view filing)May 231 daySheena JonathanDirector, Other: CO-FOUNDERSSale−1.00K$108.30−$108.3K−1.4%68.6K after4 lots10b5-1
May 17, 2024 (view filing)May 152 daysChapman Steven LeonardCEO AND PRESIDENTSSale−6.78K$107.08−$725.9K−3.0%219.5K after2 lots10b5-1
May 10, 2024 (view filing)May 10Same dayRabinowitz DanielSEC. AND CHIEF LEGAL OFFICERSSale−30.0K$104.59−$3.14M−12.8%204.5K after4 lots10b5-1
May 10, 2024 (view filing)May 10Same daySheena JonathanDirector, Other: CO-FOUNDERSSale−2.70K$105.11−$283.8K−0.8%319.1K after5 lots10b5-1
May 3, 2024 (view filing)May 12 daysBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−1.87K$93.97−$175.3K−2.7%67.5K after4 lots10b5-1
May 1, 2024 (view filing)Apr 292 daysMoshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSSale−1.20K$93.14−$111.4K−1.0%115.8K after10b5-1
May 1, 2024 (view filing)Apr 292 daysFesko JohnPRESIDENT, CHIEF BUS. OFFICERSSale−929$93.14−$86.5K−0.8%110.7K after10b5-1
May 1, 2024 (view filing)Apr 292 daysRabinowitz DanielSEC. AND CHIEF LEGAL OFFICERSSale−1.06K$93.14−$98.4K−0.5%204.5K after10b5-1
May 1, 2024 (view filing)Apr 292 daysChapman Steven LeonardCEO AND PRESIDENTSSale−4.08K$93.14−$380.4K−1.8%226.2K after10b5-1
May 1, 2024 (view filing)Apr 292 daysBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−1.24K$93.14−$115.3K−1.8%69.4K after10b5-1
Apr 26, 2024 (view filing)Apr 251 daySheena JonathanDirector, Other: CO-FOUNDERSSale−1.00K$89.55−$89.5K−1.4%69.1K after2 lots10b5-1
Apr 26, 2024 (view filing)Apr 24-262 daysBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−2.39K$91.67−$219.4K−3.3%70.6K after3 lots10b5-1
Apr 23, 2024 (view filing)Apr 23Same dayRabinowitz DanielSEC. AND CHIEF LEGAL OFFICERSSale−787$91.38−$71.9K−0.4%205.6K after10b5-1
Apr 23, 2024 (view filing)Apr 23Same dayMoshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSSale−531$91.38−$48.5K−0.5%117.0K after10b5-1
Apr 23, 2024 (view filing)Apr 23Same dayFesko JohnPRESIDENT, CHIEF BUS. OFFICERSSale−522$91.38−$47.7K−0.5%111.7K after10b5-1
Apr 23, 2024 (view filing)Apr 23Same dayChapman Steven LeonardCEO AND PRESIDENTSSale−2.55K$91.38−$233.2K−1.1%230.3K after10b5-1
Apr 23, 2024 (view filing)Apr 23Same dayBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−1.52K$91.38−$139.2K−2.0%73.0K after10b5-1
Apr 17, 2024 (view filing)Apr 161 dayMoshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSSale−80.0K$90.82−$7.27M−40.5%117.6K after2 lots10b5-1
Apr 17, 2024 (view filing)Apr 152 daysChapman Steven LeonardCEO AND PRESIDENTSSale−6.82K$93.13−$634.8K−2.9%227.7K after3 lots10b5-1
Apr 4, 2024 (view filing)Apr 31 daySheena JonathanDirector, Other: CO-FOUNDERSSale−26.7K$92.47−$2.47M−7.7%321.0K after3 lots10b5-1
Apr 4, 2024 (view filing)Apr 22 daysBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−1.38K$92.62−$127.6K−1.9%70.6K after10b5-1
Mar 29, 2024 (view filing)Mar 281 daySheena JonathanDirector, Other: CO-FOUNDERSSale−447$90.22−$40.3K−0.1%347.7K after2 lots10b5-1
Mar 29, 2024 (view filing)Mar 281 daySheena JonathanDirector, Other: CO-FOUNDERSSale−1.00K$90.13−$90.1K−1.4%69.6K after2 lots10b5-1
Mar 29, 2024 (view filing)Mar 281 dayRabinowitz DanielSEC. AND CHIEF LEGAL OFFICERSSale−743$90.42−$67.2K−0.4%204.8K after10b5-1
Mar 29, 2024 (view filing)Mar 281 dayMoshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSSale−707$90.42−$63.9K−0.4%197.6K after10b5-1
Mar 29, 2024 (view filing)Mar 281 dayFesko JohnPRESIDENT, CHIEF BUS. OFFICERSSale−464$90.42−$42.0K−0.4%112.2K after10b5-1
Mar 29, 2024 (view filing)Mar 1514 daysLateChapman Steven LeonardCEO AND PRESIDENTSSale−50.9K$89.02−$4.53M−100.0%0 after3 lots10b5-1
Mar 29, 2024 (view filing)Mar 281 dayChapman Steven LeonardCEO AND PRESIDENTSSale−2.66K$90.42−$240.7K−1.1%234.5K after10b5-1
Mar 29, 2024 (view filing)Mar 281 dayBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−914$90.42−$82.6K−1.3%72.0K after10b5-1
Mar 15, 2024 (view filing)Mar 15Same dayChapman Steven LeonardCEO AND PRESIDENTSSale−83.2K$88.96−$7.40M−26.4%232.0K after3 lots10b5-1
Mar 7, 2024 (view filing)Mar 5-62 daysSheena JonathanDirector, Other: CO-FOUNDERSSale−6.03K$88.64−$534.3K−1.3%458.6K after3 lots10b5-1
Mar 7, 2024 (view filing)Mar 52 daysRabinowitz DanielSEC. AND CHIEF LEGAL OFFICERSSale−2.16K$88.37−$190.9K−1.0%204.2K after
Mar 7, 2024 (view filing)Mar 52 daysChapman Steven LeonardCEO AND PRESIDENTSSale−9.33K$88.37−$824.1K−3.6%247.0K after
Mar 7, 2024 (view filing)Mar 52 daysBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−2.83K$88.37−$249.7K−3.8%70.6K after
Mar 7, 2024 (view filing)Mar 52 daysMoshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSSale−2.25K$88.36−$198.4K−1.1%198.3K after2 lots
Mar 7, 2024 (view filing)Mar 52 daysFesko JohnPRESIDENT, CHIEF BUS. OFFICERSSale−1.84K$88.36−$162.4K−1.6%112.7K after2 lots
Mar 7, 2024 (view filing)Mar 52 daysRabinowitz MatthewEXECUTIVE CHAIRMANSSale−1.01K$88.36−$89.4K−0.1%1.08M after2 lots10b5-1
Mar 7, 2024 (view filing)Mar 52 daysRabinowitz MatthewEXECUTIVE CHAIRMANSSale−190.0K$87.39−$16.6M−18.1%860.0K after4 lots10b5-1
Mar 1, 2024 (view filing)Feb 291 daySheena JonathanDirector, Other: CO-FOUNDERSSale−6.00K$90.02−$540.1K−29.0%14.7K after2 lots
Mar 1, 2024 (view filing)Feb 291 daySheena JonathanDirector, Other: CO-FOUNDERSSale−10.0K$86.34−$863.4K−2.1%463.6K after4 lots
Feb 29, 2024 (view filing)Feb 27-292 daysRabinowitz DanielSEC. AND CHIEF LEGAL OFFICERSSale−55.8K$80.21−$4.48M−21.5%204.2K after5 lots10b5-1
Feb 16, 2024 (view filing)Feb 16Same dayRosenman HermDirectorSSale−93.9K$69.37−$6.51M−60.4%61.7K after2 lots
Feb 8, 2024 (view filing)Feb 62 daysBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−34.0K$70.03−$2.38M−32.5%70.6K after10b5-1
Feb 8, 2024 (view filing)Feb 6-72 daysSheena JonathanDirector, Other: CO-FOUNDERSSale−7.00K$70.01−$490.1K−28.4%17.7K after4 lots10b5-1
Feb 8, 2024 (view filing)Feb 71 daySheena JonathanDirector, Other: CO-FOUNDERSSale−5.00K$70.10−$350.5K−1.0%473.6K after10b5-1
Feb 2, 2024 (view filing)Feb 11 dayBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−22.3K$67.73−$1.51M−24.0%70.6K after
Jan 30, 2024 (view filing)Jan 291 dayBrophy Michael BurkesCHIEF FINANCIAL OFFICERSSale−3.23K$65.09−$210.6K−3.4%92.9K after
Jan 30, 2024 (view filing)Jan 291 daySheena JonathanDirector, Other: CO-FOUNDERSSale−546$65.09−$35.5K−0.1%478.6K after